| Bioactivity | Lp-PLA2-IN-14 (Compound 19) is an Lp-PLA2 inhibitor with a pIC50 of 8.4 against rhLp-PLA2. Lp-PLA2-IN-14 can be used for the research of neurodegenerative related diseases, such as Alzheimer Disease (AD), glaucoma, age-related macular degeneration (AMD) or cardiovascular diseases including atherosclerosis and the like[1]. |
| Name | Lp-PLA2-IN-14 |
| CAS | 2756855-66-8 |
| Formula | C16H14F3N3O3 |
| Molar Mass | 353.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhenghua Gu, et al. Tricyclic pyrimidone compounds, preparation method, composition and application thereof. Patent CN113861220A. |
Lp-PLA2-IN-14
CAS: 2756855-66-8 F: C16H14F3N3O3 W: 353.30
Lp-PLA2-IN-14 (Compound 19) is an Lp-PLA2 inhibitor with a pIC50 of 8.4 against rhLp-PLA2. Lp-PLA2-IN-14 can be used for
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.